Cell Culture Market is Expected to Reach $51.3 billion | MarketsandMarkets.

Chicago, Aug. 25, 2023 (GLOBE NEWSWIRE) -- In the near future, the cell culture industry is poised to undergo transformative advancements that will redefine biotechnology and healthcare landscapes. With rapid progress in techniques like 3D cell culture, organoids, and microfluidics, researchers and companies will achieve unprecedented levels of cell mimicry, enabling more accurate disease modeling, drug screening, and personalized medicine development. Automation, machine learning, and high-throughput systems will streamline and accelerate the cell culture process, fostering efficient scale-up and reduced production costs. The integration of gene editing technologies like CRISPR-Cas9 will further enhance the manipulation of cellular behaviour, leading to breakthroughs in regenerative medicine and novel therapeutic strategies. Ethical considerations surrounding the use of advanced cell models and potential regulatory challenges will require careful navigation, but the cell culture industry's evolution promises to revolutionize how we understand, treat, and combat various diseases.

Cell Culture market in terms of revenue was estimated to be worth $27.9 billion in 2023 and is poised to reach $51.3 billion by 2028, growing at a CAGR of 12.9% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The growth of this market is majorly driven by the growing popularity of monoclonal antibodies, and adoption of single-use technologies. On the other hand, the disposal of plastic consumables challenges the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559

Cell Culture Market Scope:

Report Coverage	Details
Market Revenue in 2023	$27.9 billion
Estimated Value by 2028	$51.3 billion
Growth Rate	Poised to grow at a CAGR of 12.9%
Market Size Available for	2020–2028
Forecast Period	2023–2028
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product, Application, End user and Region
Geographies Covered	North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunities	Growth hotspots in emerging economies
Key Market Drivers	Adoption of single-use technologies

Cell Culture market major players covered in the report, such as:

• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Corning Incorporated (US)
• Eppendorf AG (Germany)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Lonza Group AG (Switzerland)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Getinge AB (Sweden)
• Becton, Dickinson and Company (US)
• Miltenyi Biotec (Germany)
• HiMedia Laboratories (India)
• STEMCELL Technologies Inc. (Canada)
• Solida Biotech GmbH (Germany)
• Caisson Laboratories Inc. (US)
• PromoCell GmbH (Germany)
• InvivoGen (US)
• Pan-Biotech GmbH (Germany)
• Cellexus (UK)
• Meissner Filtration Products Inc. (US)
• Adolf Kühner AG (Switzerland)
• SeraCare Life Sciences Inc. (US)
• ANGUS Chemical Company (US)
• Biospherix Ltd. (US)
• and Among Others

Buy a Cell Culture Industry Report (556 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=559

This report categorizes the cell culture market into the following segments and subsegments:

Cell culture Market, by Product

• Consumables
• Equipment

Cell culture Market, by Consumables

• Sera, Media, and Reagents
  • Media (serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other media)
  • Sera (fetal bovine sera (FBS), adult bovine sera (ABS), and other animal sera)
  • Reagents (growth factors, supplements, buffers & chemicals, cell dissociation reagents, balanced salt solutions, attachment & matrix factors, antibiotics/antimycotics, contamination detection kits, cryoprotective reagents, and other cell culture reagents)
• Vessels
  • Roller/roux bottles
  • Cell factory systems/cell stacks
  • Multiwell plates
  • Flasks
  • Petri dishes
• Accessories

Cell Culture Market, by Equipment

• Supporting Equipment (filtration systems, cell counters, carbon dioxide incubators, centrifuges, autoclaves, microscopes, biosafety cabinets, other supporting equipment)
• Bioreactors (conventional bioreactors, single-use bioreactors)
• Storage Equipment (Refrigerators & freezers, Cryostorage systems)

Cell culture Market, by Application

• Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
• Diagnostics
• Drug Screening & Development
• Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
  • Other tissue engineering & regenerative medicine applications
• Other Applications

Cell culture Market, by End user

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other End Users

Cell culture Market, by region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
  • Brazil
  • Mexico
  • RoLATAM
• Middle East and Africa (MEA)

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=559

The key stakeholders in the Cell Culture market include:

• Research Institutions and Academia: Universities, research centers, and academic institutions are crucial stakeholders as they drive fundamental research, innovation, and advancements in cell culture techniques and applications.
• Biotechnology and Pharmaceutical Companies: These organizations heavily rely on cell culture for drug discovery, development, and production. They invest in optimizing cell culture methods to create novel therapies and pharmaceutical products.
• Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs): CROs and CMOs provide specialized services in cell culture, offering expertise and infrastructure for research and production to biotech and pharmaceutical companies.
• Equipment and Reagent Suppliers: Companies that manufacture and supply equipment, consumables, and reagents necessary for cell culture, such as culture media, growth factors, sera, bioreactors, and cell culture vessels.
• Technology Providers: Developers of cutting-edge technologies like 3D cell culture systems, bioreactors, and automation solutions that enhance efficiency, scalability, and reproducibility in cell culture processes.
• Regulatory Agencies: Government regulatory bodies ensure that cell culture practices comply with safety and quality standards, especially in the context of producing biological products for therapeutic use.
• Ethics Committees and Bioethicists: As cell culture methods advance, ethical considerations regarding the use of human and animal cells, genetic modifications, and emerging technologies play a critical role in shaping regulations and guidelines.
• Investors and Venture Capitalists: Provide funding and support to companies and research initiatives focused on cell culture technologies, driving innovation and commercialization.
• Patient Advocacy Groups: Stakeholders who advocate for the use of cell culture in disease modeling and drug development to address unmet medical needs and promote patient-centric approaches.
• Government Agencies: Government bodies invest in research, create policies, and support initiatives that foster growth and innovation within the cell culture industry, contributing to its overall development.
• Healthcare Providers and Clinicians: End-users of cell culture-derived therapies and diagnostic tools, playing a pivotal role in the implementation of personalized medicine and improved patient outcomes.
• Public and Private Research Funding Organizations: Funding agencies and foundations provide grants and financial support for research projects focused on advancing cell culture techniques and applications.

These stakeholders collectively shape the direction, growth, and ethical considerations of the cell culture market, contributing to its continued evolution and impact on various sectors, including healthcare, biotechnology, and pharmaceuticals.

Recent Developments:

• In February 2022, Thermo Fisher Scientific announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the US.
• In October 2022, Cytiva acquired Cevec Pharmaceuticals GmbH, which is expected to strengthen Cytiva’s leading position in biomanufacturing solutions.

Frequently Asked Questions (FAQs) of Cell Culture Market:

Question 1. Who are the key players in the cell culture market?
Answer: Key players in the Cell Culture Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany). 

Question 2: Which product segment dominates the cell culture market?
Answer: The consumables segment dominated the cell culture market in 2022. Serum, media, and reagents; vessels; and accessories are the subcategories of cell culture consumables. The sera, media, and reagents segment is expected to dominate the cell culture consumables markets. The large share of this segment is attributed to the repeated purchase and requirement of sera, media, and reagents in bulk quantities for various cell culture applications.          

Question 3: Which application segment of the cell culture market is expected to witness the highest growth?
Answer: The biopharmaceutical production segment is expected to grow the most. This segment's rapid growth can be attributed to the commercial expansion of major pharmaceutical and biotechnology companies, rising demand for mAbs, and an increase in regulatory approvals for the production of cell culture-based vaccines.

Question 4: What is the market size for the cell culture market?
Answer: The global cell culture market is projected to reach USD 51.3 billion by 2028 from USD 27.9 billion in 2023, at a CAGR of 12.9% during the forecast period of 2023 to 2028.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=559

Report Objectives:

• To define, describe, and forecast the global cell culture market based on product, application, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cell culture market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
• To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
• To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the cell culture market

Related Reports:

3D Cell Culture Market

Microcarrier Market

Cell-based Assays Market

Single Use Bioprocessing Market

Stem Cell Manufacturing Market

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-culture-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/cell-culture.asp

            About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com